Searched for
SRINIVASAN NAMALA
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Protein drinks muscle up to enter mainstream marketProtein-based foods have expanded from gym-centric products to mainstream consumption, with brands introducing affordable and diverse forma...
- Bain Capital Private Equity to acquire Porus LabsFounded in 1994 in Hyderabad, Porus Labs is active in segments such as speciality polymers, electronic chemicals and agrochemicals.
- Aten Porus Lifesciences: Firm is developing drugs to fight a host of rare diseases globallyTo begin with, the duo decided to focus on Niemann-Pick Type C (NPC) disorder that’s also referred to as Childhood Alzheimer’s.
Load More